Welcome life-saving Parliamentary EDM 175!

Dr. Lisa Cameron MP has tabled a crucial new Parliamentary Early Day Motion, EDM 175, calling for the Government to mandate a public scientific hearing – judged by independent experts from the relevant fields of science – on claims that veterinary principles, from animal experiments, should be applied to human patients in medical research and safety testing.

The science hearing will expose and judge false claims about current medical knowledge that maintain the funding of animal experiments; the hearing will enable our Government to become aware that they are being duped by an outdated 173-year-old vested interest, which is today entirely out of step with current medical and scientific understanding.

The EDM cites high profile examples of the failure of animal testing being reported in peer reviewed medical journals, including the British Medical Journal [1]; the FDA – which states that 9 out of 10 new human medicines fails to pass human clinical trials, because animals cannot predict human responses [2]; pharmaceutical companies, whose experts openly acknowledge the failure of animal tests in their drug development process [3] – and the US-based National Cancer Institute, which says we have lost cures for cancer because studies in rodents have been believed [4].

Please ask your MP to sign EDM 175, for a fair and open science hearing to expose and stop the selfish people who’s livelihoods depend upon an outdated method of medical research, which is now proven to be harming and killing human patients. Please simply type in your postcode at this link, to ask your MP to sign the EDM today.


1. BMJ 2014; 348: g 3719 (availabe here)

2. FDA Issues Advice to Make Earliest Stages Of Clinical Drug Development More Efficient. FDA, June 18, 2009 2006 [cited March 7, 2010].

3. Extensive quotes, by experts working for the pharmaceutical industry, on the failure of animal models in their drug development process, available here.

4. Gura T: ‘Cancer Models: Systems for identifying new drugs are often faulty’. Science. 1997, 278 (5340): 1041-1042.